At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 890 enrolled
Drug / intervention
Clindamycin and Benzoyl Peroxide Gel (combination) +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating Clindamycin and Benzoyl Peroxide Gel (combination), Clindamycin and Benzoyl Peroxide Gel (Reference) (combination), and 1 other intervention for Acne. Completed, enrolled 890 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment acne vulgaris
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedAug 2015
Primary CompletionApr 2016
Study CompletionJun 2016
TodayJul 2026
First PostedAug 4, 2015
Enrollment StartJul 1, 2015
Primary CompletionApr 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.9 years ago
Interventions
Clindamycin and Benzoyl Peroxide Gel (combination)drug
Clindamycin and Benzoyl Peroxide Gel (Reference) (combination)drug
Placebo gel (combination)drug